These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3034619)

  • 1. Possibility of elevated parathyroid function in patients with calcium-containing nephrolithiasis as compared with normal controls.
    Kitamura T; Hirano Y; Ueda D; Niijima T
    Eur Urol; 1987; 13(1-2):90-9. PubMed ID: 3034619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical changes before and during oral calcium tolerance test in calcium stone formers.
    Kitamura T; Hirano Y; Ueda D; Aso Y
    Urol Res; 1988; 16(3):149-55. PubMed ID: 2842910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria.
    Pak CY; Oata M; Lawrence EC; Snyder W
    J Clin Invest; 1974 Aug; 54(2):387-400. PubMed ID: 4367891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Suppressibility of parathyroid function in primary hyperparathyroidism as estimated by nephrogenous cyclic AMP (author's transl)].
    Sohn HE; Yumita S; Unakami H; Miura R; Furukawa Y
    Nihon Naibunpi Gakkai Zasshi; 1982 Feb; 58(2):110-21. PubMed ID: 6282661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of dietary calcium on serum 1,25-dihydroxyvitamin D concentrations in renal stone formers.
    D'Amour P; Gascon-Barré M; Dufresne L; Perreault JP
    Clin Endocrinol (Oxf); 1984 Nov; 21(5):549-62. PubMed ID: 6094046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiological studies in idiopathic hypercalciuria: use of an oral calcium tolerance test to characterize distinctive hypercalciuric subgroups.
    Broadus AE; Dominguez M; Bartter FC
    J Clin Endocrinol Metab; 1978 Oct; 47(4):751-60. PubMed ID: 233682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The pathogenesis of hypercalciuria from the aspect of the response to human parathyroid hormone in Ca containing stone formers].
    Taguchi K; Kuwahara M; Kambe K; Ioritani N; Saitoh T; Shirai S; Orikasa S; Mizunashi K; Furukawa Y
    Nihon Hinyokika Gakkai Zasshi; 1992 Jul; 83(7):1101-9. PubMed ID: 1507727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathogenesis of idiopathic hypercalciuria: evidence for parathyroid hyperfunction.
    Evans RA; Hills E; Wong SY; Wyndham LE; Eade Y; Dunstan CR
    Q J Med; 1984; 53(209):41-53. PubMed ID: 6324269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria.
    Kaplan RA; Haussler MR; Deftos LJ; Bone H; Pak CY
    J Clin Invest; 1977 May; 59(5):756-60. PubMed ID: 192763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of secondary hyperparathyroidism in most patients with renal hypercalciuria.
    Olmer M; Berland Y; Argemi B
    Kidney Int Suppl; 1983 Dec; 16():S175-9. PubMed ID: 6330424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal handling of calcium in hypercalciuric calcium oxalate nephrolithiasis.
    Colette C; Percheron C; Pham CT; Boniface H; Thomas N; Guiter J; Monnier L
    Miner Electrolyte Metab; 1993; 19(6):377-84. PubMed ID: 8164620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria.
    Pak CY; Britton F; Peterson R; Ward D; Northcutt C; Breslau NA; McGuire J; Sakhaee K; Bush S; Nicar M; Norman DA; Peters P
    Am J Med; 1980 Jul; 69(1):19-30. PubMed ID: 6247914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrogenous cyclic adenosine monophosphate levels in normocalcemic cancer patients: its significance.
    Abramson EC; Kukreja SC; Lad TE; Shemerdiak WP; York PA
    Horm Metab Res; 1984 Apr; 16(4):204-7. PubMed ID: 6327481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrogenous adenosine 3'5' monophosphate as an index of parathyroid function in chronic renal disease.
    Czekalski S; Baczyk K
    Proc Eur Dial Transplant Assoc; 1977; 14():451-60. PubMed ID: 202946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study of calcium metabolism in calcium-containing stone formers].
    Ikeda M; Ohmori A
    Nihon Hinyokika Gakkai Zasshi; 1995 Aug; 86(8):1313-21. PubMed ID: 7474614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers.
    Bataille P; Achard JM; Fournier A; Boudailliez B; Westeel PF; el Esper N; Bergot C; Jans I; Lalau JD; Petit J
    Kidney Int; 1991 Jun; 39(6):1193-205. PubMed ID: 1895673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maximal PTH secretory rate and set point for calcium in normal subjects and patients with primary hyperparathyroidism. In vivo studies.
    Gardin JP; Patron P; Fouqueray B; Prigent A; Paillard M
    Miner Electrolyte Metab; 1988; 14(4):221-8. PubMed ID: 2850460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral calcium tolerance test and serum calcitonin in calcium stone formers.
    Kohri K; Kataoka K; Iguchi M; Yachiku S; Kurita T
    Urol Res; 1983; 11(1):33-7. PubMed ID: 6304968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of an oral sodium phosphate load on parathyroid hormone and fibroblast growth factor 23 secretion in normo- and hypercalciuric stone-forming patients.
    Irzyniec T; Boryń M; Kasztalska J; Nowak-Kapusta Z; Maciejewska-Paszek I; Grochowska-Niedworok E
    Clin Nutr; 2020 Dec; 39(12):3804-3812. PubMed ID: 32386861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrogenous cyclic AMP as a parathyroid function test.
    Broadus AE
    Nephron; 1979; 23(2-3):136-41. PubMed ID: 220548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.